Crinetics Pharmaceuticals, Inc.
CRNX
$46.98
$1.974.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.09B | 1.20B | 1.27B | 1.35B | 862.67M |
| Total Receivables | -- | -- | 7.31M | 8.47M | 6.94M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 28.48M | 20.40M | 5.25M | 10.43M | 6.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 500.00K | 500.00K | 4.37M | 2.42M | 1.88M |
| Total Current Assets | 1.12B | 1.22B | 1.29B | 1.38B | 877.59M |
|
|
|||||
| Total Current Assets | 1.12B | 1.22B | 1.29B | 1.38B | 877.59M |
| Net Property, Plant & Equipment | 55.52M | 56.57M | 55.32M | 55.58M | 55.98M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.23M | 15.74M | 12.95M | 1.63M | 1.81M |
| Total Assets | 1.20B | 1.29B | 1.36B | 1.43B | 937.37M |
|
|
|||||
| Total Accounts Payable | 6.11M | 11.33M | 9.84M | 5.85M | 4.94M |
| Total Accrued Expenses | 59.96M | 48.56M | 38.38M | 44.49M | 39.28M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.44M | 6.61M | 6.88M | 7.15M | 7.41M |
| Total Finance Division Other Current Liabilities | 1.64M | 1.90M | 2.21M | 2.19M | 1.93M |
| Total Other Current Liabilities | 1.64M | 1.90M | 2.21M | 2.19M | 1.93M |
| Total Current Liabilities | 74.16M | 68.40M | 57.31M | 59.68M | 53.56M |
|
|
|||||
| Total Current Liabilities | 74.16M | 68.40M | 57.31M | 59.68M | 53.56M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 42.70M | 43.33M | 43.94M | 44.57M | 45.13M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.00M | 6.33M | 6.08M | 5.53M | 5.71M |
| Total Liabilities | 123.86M | 118.05M | 107.33M | 109.79M | 104.39M |
|
|
|||||
| Common Stock & APIC | 2.36B | 2.33B | 2.30B | 2.28B | 1.70B |
| Retained Earnings | -1.29B | -1.16B | -1.05B | -952.11M | -871.52M |
| Treasury Stock & Other | 2.08M | 1.51M | 2.00M | 963.00K | 2.04M |
| Total Common Equity | 1.07B | 1.17B | 1.25B | 1.32B | 832.98M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.07B | 1.17B | 1.25B | 1.32B | 832.98M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.07B | 1.17B | 1.25B | 1.32B | 832.98M |
|
|
|||||